美股
Lead report
P3 Health Partners forecasts $80M-$110M in 2026 adjusted EBITDA following Q2 settlements (NASDAQ:PIII)
P3 Health Partners (PIII) Q2 2026 earnings call recap: EBITDA beat, raised 2026 outlook, settlement impacts, seasonality risks & strategy.
